Elekta strengthens its internal audit and compliance functions


STOCKHOLM, September 11, 2014 - Elekta has appointed Helene Vibbleus as new
Chief Audit Executive and Caroline Mofors as Group Compliance Officer. Through
both of these recruitments, Elekta continues to develop its internal audit and
compliance functions, while strengthening the Group's capacity for risk
management and internal control. Helene and Caroline will report their
observations and actions directly to the Board and Audit Committee.
Helene Vibbleus has previously worked at Electrolux, as head of the internal
audit function and on PwC as auditor and partner. Helene also has extensive
experience as a director and member of the audit committee from several
companies.
Caroline Mofors comes to Elekta from Ericsson, where she worked with Compliance
and legal issues. Previously, Caroline worked at the Swedish law firm Vinge.

# # #

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 15:00 CET on September 11, 2014.
About Elekta
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing
software systems across the spectrum of cancer care. Stretching the boundaries
of science and technology, providing intelligent and resource-efficient
solutions that offer confidence to both health care providers and patients,
Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,800 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker STO:EKTAB. Website:
www.elekta.com.

Attachments

09110180.pdf